Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop® System with Contrast Agents

Prospective study is designed to evaluate the feasibility and visualization benefits of contrast-enhanced ultra-low-field portable MRI.

ACA Pharma Named Exclusive Distributor for Ferabright™ in Macau, Hong Kong, Singapore, Greater Bay Area & Mainland China

ACA Pharma: [email protected] Azurity Pharmaceuticals: [email protected] ...
Business Wire

Bayer’s investigational MRI contrast agent gadoquatrane meets primary and main secondary endpoints in pivotal Phase III studies

BERLIN--(BUSINESS WIRE)--Bayer, a global leader in radiology, today announced positive topline results of the pivotal Phase III QUANTI studies evaluating the efficacy and safety of gadoquatrane, an ...
Neurology Advisor

Medical Imaging Contrast Media Contribute to Environmental Pollution

Contrast media used for medical imaging may be contributing to environmental pollution as researchers measure and consider the impact.
The Robesonian

Roach: Man experiences symptoms of excess thyroid after MRI

You are also right that the iodine-containing dye from CT scans can precipitate hyperthyroidism in a person who is destined to get it. However, the risk of this occurring is low. There is no increased ...
ascopubs.org

Non-contrast MRI as a surveillance tool for recurrent hepatocellular carcinoma after curative treatment: A prospective multicenter intra-individual comparison trial.

Hepatocellular carcinoma: A 30-year trend analysis of global burden stratified by risk factors, and socio-demographic indexes. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal ...

ISMI Introduces a Radiologist-Led Full-Body MRI Program Focused on Diagnostic Clarity and Long-Term Health Planning

ISMI offers a radiologist-led Full-Body MRI in Montreal to identify life-saving findings, detect health risks, and support ...

Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop(R) System with Contrast Agents

(Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain--the Swoop (R) system--today ...